Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DSNKY
Recent news which mentions DSNKY
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor
April 08, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
FDA
AZN
Briefs
From
Benzinga
What's Going On With Pfizer Stock Today?
January 25, 2024
Tickers
DSKYF
DSNKY
NEWS
PFE
Tags
Health Care
General
News
From
Benzinga
Why Pharmaceutical Company Esperion Therapeutics Shares Are Diving Today
January 03, 2024
Tickers
DSNKY
ESPR
NEWS
Tags
Market News
Equities
Legal
From
Benzinga
Japan Emerges As Promising 2024 Investment Destination: 3 Stocks To Consider
December 20, 2023
Tickers
ASIA
CCOEY
DSNKY
EWJ
Tags
SONY
NMR
Belinda Bao
From
Benzinga
Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?
October 31, 2023
Tickers
DSNKY
MRK
Tags
Recent Press Releases
Market News
MRK
From
Motley Fool
Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting
September 22, 2023
Tickers
AZN
DSKYF
DSNKY
Tags
Biotech
Market News
DSNKY
From
Benzinga
AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials
September 11, 2023
Tickers
AZN
DSKYF
DSNKY
Tags
DSNKY
Biotech
Market News
From
Benzinga
FDA Greenlights Daiichi Sankyo's Blood Cancer Drug, A Promising Competitor to Novartis' Rydapt
July 21, 2023
Tickers
DSKYF
DSNKY
NVS
Tags
News
Briefs
FDA
From
Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
July 04, 2023
Tickers
BETRF
CYBN
DMTTF
DSNKY
Tags
Offerings
Cannabis
Earnings
From
Benzinga
AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial
July 03, 2023
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Market News
Biotech
Equities
From
Benzinga
Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines
June 27, 2023
Tickers
DSNKY
Tags
Contracts
Psychedelics
Markets
From
Benzinga
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
March 20, 2023
Tickers
DSKYF
DSNKY
ZYME
Tags
Briefs
News
General
From
Benzinga
First Republic Bank sinks on possible sale reports, and Credit Suisse’s stock boosted by central bank borrowing
March 16, 2023
Tickers
ADBE
BIDU
CS
DSNKY
Tags
DSNKY
VORB
SNAP
From
MarketWatch
AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid Tumor Setting
March 06, 2023
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSNKY
Biotech
Market News
From
Benzinga
Is Gilead Sciences a Good Stock to Buy Now?
February 06, 2023
Tickers
AZN
DSNKY
GILD
PFE
Tags
GILD
Market News
PFE
From
Motley Fool
Daiichi Sankyo Seeks Approval In Japan For Its mRNA-Based COVID-19 Vaccine
January 13, 2023
Tickers
DSKYF
DSNKY
Tags
Health Care
Benzinga
DSKYF
From
Benzinga
AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
December 19, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSKYF
Benzinga
News
From
Benzinga
AstraZeneca Highlights First Results From Datopotamab Study In Pretreated Breast Cancer Patients
December 09, 2022
Tickers
AZN
AZNCF
DSNKY
Tags
Health Care
Benzinga
General
From
Benzinga
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
November 14, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSNKY
Eurasia
Market News
From
Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Market News
Price Target
Biotech
From
Benzinga
Why MacroGenics Stock Sank Today
September 12, 2022
Tickers
DSNKY
MGNX
Tags
Market News
Recent Press Releases
MGNX
From
Motley Fool
This Cancer Focused Stock Has 60% Potential Upside, Bullish Analyst Says
September 12, 2022
Tickers
DSNKY
RAIN
Tags
Health Care
why it's moving
RAIN
From
Benzinga
3 Top Stocks to Invest In Right Now
August 16, 2022
Tickers
AZN
DSNKY
HSY
MRK
Tags
MRK
NYSE:NVO,NASDAQ:MSFT,NYSE:MRK,NASDAQ:SGEN,OTCMKTS:DSNKY,NASDAQ:AZN,NYSE:HSY
Market News
From
InvestorPlace
Seagen Suffers Loss In Arbitration Dispute Over ADC Technology
August 15, 2022
Tickers
DSKYF
DSNKY
MRK
SGEN
Tags
Benzinga
DSKYF
General
From
Benzinga
AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study
August 15, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSNKY
AZNCF
Biotech
From
Benzinga
Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
August 12, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
AZNCF
Biotech
Market News
From
Benzinga
AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients
August 09, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Biotech
Market News
AZNCF
From
Benzinga
Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact
July 25, 2022
Tickers
AZN
DSNKY
ENVB
IBB
Tags
SYN
Penny Stocks
Biotech
From
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
July 19, 2022
Tickers
ACAD
APLS
AVDL
AZN
Tags
RARE
AVDL
Health Care
From
Benzinga
AstraZeneca's Enhertu Wins European Approval For Pretreated Breast Cancer Setting
July 19, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSNKY
AZNCF
Market News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.